// App-Quantinova.ai

1551 : Are immunohistochemical (IHC)/microsatellite instability (MSI) testing necessary as part of Lynch syndrome work-up in the era of multiplex genetic testing?

Researchers

Presenter

  • Ahmad Fitri Idris

Principal Investigators

  • Simon D. Hooper

  • E Berkley

  • David J. Gallagher

  • M. P. Farrell

  • Carmel Nolan

  • Roisin Clarke

Medical Centers

  • Mater Private Hospital and Mater Misericordiae University Hospital, Dublin, Ireland

  • Mater Misericordiae University Hospital, Dublin, IrelandMater Misericordiae University Hospital, Mater Private Hospital, Dublin, IrelandCancer Genetics, Dublin, Ireland

  • The Mater Hospital, Dublin, Ireland

  • Department of Cancer Genetics, Dublin, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lynch syndrome

  • Solid malignancies

Biomarkers

  • Microsatellite instability

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved